Author ORCID Identifier
https://orcid.org/0000-0002-4614-7222
Abstract
Abstract
Introduction: Atrial fibrillation remains a pervasive global health concern, contributing significantly to the incidence of stroke, heart failure, sudden death, and overall cardiovascular morbidity.
Materials and methods: The present study undertook a retrospective analysis involving a meticulous examination of 127 patients, representing a diverse cohort of individuals encompassing 73 men (with a median age of 62 and a range of 37-75) and 54 women (with a median age of 60 and a range of 42-78) duration of atrial fibrillation 48 hours or less.
Results: The results highlighted amiodarone's remarkable efficiency, as it successfully converted 81.2% of cases (56 out of 69 patients) to sinus rhythm. In comparison, propafenone also demonstrated considerable efficacy, converting 78.8% of cases (26 out of 33 patients) to sinus rhythm. the most striking results were observed with electrical cardioversion, achieving an impressive 96.0% success rate (24 out of 25 patients). (p
Conclusion: In conclusion, the combination of amiodarone, propafenone, and electrical cardioversion offers an array of effective tools for restoring sinus rhythm in patients with atrial fibrillation. To further enhance patient care, medical practitioners should prioritize the consideration of atrial fibrillation duration when deciding on the most appropriate treatment plan within the emergency department.
Publication Date
8-2023
Publisher
Mihails Tracevskis, Assoc. Prof. Irina Pupkeviča
First Page
169
Last Page
179
Conflict of Interest
Authors declare no conflict of interest.
Keywords
atrial fibrillation, sinus rhythm, treatment
Word Count
2427
Recommended Citation
Tracevskis M.
Effectiveness of amiodarone, propafenone and synchronized electrical cardioversion for conversion of atrial fibrillation paroxysm to sinus rhythm in Rigas Stradins University Hospital department of emergency medicine..
Digital Journal of Clinical Medicine.
2023;
5(4):
169-179.
doi:
https://doi.org/10.55691/2582-3868.1140
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Included in
Diseases Commons, Health Information Technology Commons, Medical Education Commons, Medical Sciences Commons, Medical Specialties Commons, Mental and Social Health Commons, Psychiatry and Psychology Commons, Public Health Education and Promotion Commons